Intel, Pfizer, Trump Media and Target rise premarket; Apple falls By Investing.com

Investing.com – U.S. stocks rose sharply on Monday, as traders remained cautious ahead of the Federal Reserve’s latest policy meeting.

Here are some of the biggest moves in U.S. stocks before the market opens today.

  • Pfizer (NYSE:) shares rose 0.5% after the drugmaker said its experimental drug to combat a condition that causes cancer patients to lose their appetite and weight showed positive results in a mid-stage trial.

  • Boeing General Electric Manufacturing (NYSE:GE) shares rose 0.3%, after falling more than 3% on Friday, as a strike by more than 30,000 workers continued into its fourth day on Monday, with company and union negotiators set to resume talks on a labor contract on Tuesday.

  • Intel Nasdaq:NASDAQ …

  • Tesla (Nasdaq:) shares rose 0.1% after the electric vehicle maker reported a 1.2% increase in registrations in July, driven by deliveries of 5,175 Cybertrucks, according to S&P Global Mobility data.

  • apple Apple Inc (NASDAQ:) shares fell 2.3% after initial demand for the tech giant’s iPhone 16 series appeared disappointing, according to analysts at Jefferies and Citi.

  • goal (NYSE:) shares rose 0.3% after the retailer said it will hire about 100,000 seasonal employees, in line with what it has hired over the past three years, as the retailer prepares for the all-important holiday period.

  • Apollo Global Management (NYSE:) stock rose 1.2% after the asset manager said it B B Shell (NYSE:), up 0.2%, announced a $1 billion deal to finance the British energy giant’s stake in a trans-Adriatic pipeline.

  • Trump Media and Technology Group Facebook (NASDAQ:FB) shares rose 1.2%, adding to gains of about 12% on Friday, after former President Donald Trump said he would not sell the social media company’s shares when his ban ends. Trump survived an apparent second assassination attempt on Sunday, weeks before the closely watched U.S. presidential election.

ApplefallsIntelInvesting.comMediaPfizerPremarketRisetargetTrump